The Enterprise Value as of March 2026 (TTM) for Xenon Pharmaceuticals Inc. (XENE) is 4.40B

According to Xenon Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.40B. This represents a change of 55.55% compared to the average of 2.83B of the last 4 quarters.

Xenon Pharmaceuticals Inc. (XENE) Historical Enterprise Value (quarterly & annually)

How has XENE Enterprise Value performed in the past?

The mean historical Enterprise Value of Xenon Pharmaceuticals Inc. over the last ten years is 1.38B. The current 4.40B Enterprise Value has changed 31.83% with respect to the historical average. Over the past ten years (40 quarters), XENE's Enterprise Value was at its highest in in the December 2025 quarter at 3.36B. The Enterprise Value was at its lowest in in the December 2019 quarter at -8305000.00.

Xenon Pharmaceuticals Inc. (XENE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Xenon Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Xenon Pharmaceuticals Inc. (XENE) Average Enterprise Value

How has XENE Enterprise Value performed in the past?

The current Enterprise Value of Xenon Pharmaceuticals Inc. (XENE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Xenon Pharmaceuticals Inc. (XENE) Enterprise Value vs. Peers

How is XENE’s Enterprise Value compared to its peers?

Xenon Pharmaceuticals Inc.’s Enterprise Value is greater than Centessa Pharmaceuticals plc (3.61B), greater than Apogee Therapeutics, Inc. (3.86B), less than ASCENTAGE PHARMA GROUP INTERNATIONAL (15.72B), greater than Ultragenyx Pharmaceutical Inc. (2.90B), less than Celcuity Inc. (5.53B), greater than Zai Lab Limited (1.52B), less than CG Oncology, Inc. Common stock (5.40B), greater than Scholar Rock Holding Corporation (3.87B), greater than Travere Therapeutics, Inc. (2.81B), greater than Legend Biotech Corporation (1.24B),

Build a custom stock screener for Xenon Pharmaceuticals Inc. (XENE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xenon Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xenon Pharmaceuticals Inc. (XENE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xenon Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.